Professor Amrita Ahluwalia
Co-Director of the WHRI and Professor of Vascular Pharmacology; WCP2022 General Secretary
Country: United Kingdom
Specialty/Research area: Cardiovascular
Online profile: https://orcid.org/0000-0001-7626-6399
Amrita is Co-Director of The William Harvey Research Institute, Director of The UKCRC accredited Barts Cardiovascular Clinical Trials Unit (CVCTU since inception in ) and Professor of Vascular Pharmacology (2006). Amrita has co-lead the development of the research focus of The Barts Heart Centre through a Barts Charity Cardiovascular Programme Award (2015-current) including establishment of the Barts CVCTU. Amrita is a Principal Investigator at QMUL leading the Vascular Pharmacology Group. Her research focuses on understanding the role of inflammation in cardiac and vascular disease with a focus upon the non-canonical pathway for NO generation; the nitrate-nitrite-NO pathway. Amrita has lead translational studies in healthy volunteers and patients. She received the GSK Prize for Clinical Pharmacology (2012) from the BPS and the Women In Science & Engineering (WISE) Prize for Research in 2015.
Amrita is Editor-In-Chief of The British Journal of Pharmacology (2016-current), a Fellow of The British Pharmacological Society and is a member of the NC-IUPHAR Nomenclature Committee (2016-current), the NC3Rs Review Committee (2017-current) and the ARRIVE Guidelines Panel. Amrita has served as a member of the BPS Education (2007-2010) and Executive Committees and Council (2004-2006), and as Chair of The Women In Pharmacology Group (2007-2010). Amrita is committed to equality in the workplace and has led numerous initiatives supporting both gender and racial equality in the workplace.